Edgewise Therapeutics, Inc. · NASDAQ:EWTX
Orbimed Advisors LLC reported a 14.50% stake in Edgewise Therapeutics, Inc. (Schedule 13D/A)
Event May 9, 2025 · Filed May 12, 2025
Orbimed Advisors LLC reported a 14.50% stake in Edgewise Therapeutics, Inc., 15,252,867 shares, with active intent on May 9, 2025. Filed May 12, 2025 (Schedule 13D/A).
- Stake
- 14.50%
- Shares
- 15,252,867
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 14.50% | 15,252,867 |
| ORBIMED CAPITAL GP VI LLC | 14.10% | 14,809,075 |
| OrbiMed Genesis GP LLC | 0.40% | 443,792 |
| ORBIMED CAPITAL LLC | 0.30% | 265,625 |